5% STAKE4594.TTSECAYMAN ISLANDS

Evo Fund lowers stake in BrightPath Biotherapeutics to 23.14%

Stake history

22%24%26%24.41%PriorPrior: 24.41% · prior ratio stated in S100U3IF23.14%Jul 25Jul 25: 23.14% · S100U3IF
22%24%26%24.41%PriorPrior: 24.41% · prior ratio stated in S100U3IF23.14%Jul 25Jul 25: 23.14% · S100U3IF

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-07-25 10:39 JST concerning BrightPath Biotherapeutics Co., Ltd. Reported holding ratio: 23.14%, previous report: 24.41%.

Open the price chart on TradingView.

Source: EDINET S100U3IF ↗ · PDL1.0 · Not investment advice